GleamWall
中文EN

AGIO AGIOS PHARMACEUTICALS, INC.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1439222 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY214.4%
TTM net income YoY7.1%
TTM EPS YoY10.0%
Revenue 3-yr CAGR80.3%
Net income 3-yr CAGR—

Margins

Gross margin93.8%
Operating margin-297.7%
Net margin-264.8%
FCF margin-238.5%
EBITDA margin—

Returns

ROE-32.9%
ROA-30.4%
ROIC (approx.)-32.4%
Asset turnover0.11x

Leverage & solvency

Liabilities / assets8.0%
Debt / equity0.00x
Current ratio9.69x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.89x
Accruals ratio-3.4%
Payout ratio—
Capex / revenue3.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$54.03M$36.50M
Cost of revenue$6.34M$4.17M
Gross profit$47.68M$32.33M
R&D expense$339.54M$301.29M
SG&A expense$180.28M$156.78M
Operating income-$472.13M-$425.74M
Pretax income-$413.80M$717.97M
Income tax-$1.02M$44.24M
Net income-$412.78M$673.73M
EBITDA-$466.93M-$420.04M
EPS (basic)-7.1211.86
EPS (diluted)-7.1211.64
Weighted avg. shares (diluted)57.97M57.89M
Balance sheet
Cash & equivalents$89.13M$76.25M
Short-term investments$765.29M$817.46M
Inventory$32.92M$27.62M
Current assets$942.05M$965.60M
PP&E, net$10.78M$11.68M
Total assets$1.30B$1.66B
Current liabilities$82.21M$81.16M
Total liabilities$104.11M$122.24M
Shareholders' equity$1.19B$1.54B
Shares outstanding58.45M57.16M
Cash flow statement
Operating cash flow-$372.98M-$389.84M
Capital expenditure$4.32M$1.69M
Free cash flow-$377.29M-$391.53M
Investing cash flow$377.18M$363.44M
Financing cash flow$8.68M$14.44M
Depreciation & amortization$5.20M$5.70M
Stock-based compensation$52.55M$42.85M

Free plan shows the latest 2 periods; Pro shows all 15 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.